Should Investors Avoid Sharps Compliance (NASDAQ:SMED) Shares? BidaskScore Has Just Downgraded Them

Sharps Compliance Corp. (NASDAQ:SMED) Logo

Investors sentiment decreased to 0.45 in Q4 2018. Its down 0.88, from 1.33 in 2018Q3. It is negative, as 3 investors sold Sharps Compliance Corp. shares while 8 reduced holdings. 2 funds opened positions while 3 raised stakes. 3.29 million shares or 3.99% less from 3.43 million shares in 2018Q3 were reported.

Barclays Public Limited, United Kingdom-based fund reported 1,338 shares. Bank & Trust Of Mellon Corp holds 0% of its portfolio in Sharps Compliance Corp. (NASDAQ:SMED) for 13,725 shares. Quantum Cap Mgmt invested in 1.04% or 519,346 shares. Moreover, Citigroup has 0% invested in Sharps Compliance Corp. (NASDAQ:SMED) for 1,944 shares. Lapides Asset Management Limited Liability Company holds 0.2% in Sharps Compliance Corp. (NASDAQ:SMED) or 145,400 shares. Blackrock invested in 107,262 shares. North Star Inv reported 0.12% of its portfolio in Sharps Compliance Corp. (NASDAQ:SMED). Renaissance Technologies Ltd Llc invested in 449,900 shares. Northern Trust Corp has 38,613 shares. New York-based Morgan Stanley has invested 0% in Sharps Compliance Corp. (NASDAQ:SMED). 521 were reported by Tower Research Ltd Company (Trc). Ingalls Snyder Ltd Com has 305,690 shares. Brandywine Glob Invest Ltd Liability Corp holds 0.01% or 291,900 shares. Blair William And Il owns 10,000 shares for 0% of their portfolio. 512,776 were reported by Vanguard Gp.

Sharps Compliance (NASDAQ:SMED) Receives a Downgrade

Sharps Compliance (NASDAQ:SMED) shares were downgraded by BidaskScore to a Sell rating in an analyst report sent to investors on Thursday morning.

The stock decreased 0.54% or $0.02 during the last trading session, reaching $3.7. About 13,841 shares traded. Sharps Compliance Corp. (NASDAQ:SMED) has declined 16.52% since March 15, 2018 and is downtrending. It has underperformed by 20.89% the S&P500.

Analysts await Sharps Compliance Corp. (NASDAQ:SMED) to report earnings on April, 24. They expect $-0.01 earnings per share, up 80.00 % or $0.04 from last year’s $-0.05 per share. After $0.05 actual earnings per share reported by Sharps Compliance Corp. for the previous quarter, Wall Street now forecasts -120.00 % negative EPS growth.

Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. The company has market cap of $59.70 million. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste and used healthcare materials generated outside the hospital and health care facility settings; TakeAway Medication Recovery System, a solution that facilitates the proper disposal of unused medications; MedSafe, a solution for the safe collection, transportation, and proper disposal of unwanted and expired prescription medications; and ComplianceTRAC, a Web compliance and training program. It currently has negative earnings. The firm also provides Route-Based Pickup Service, a waste management service, which offers medical and hazardous waste pick-up services; TakeAway Recycle System, a solution for the collection and recycling of single-use medical devices from surgical centers and other healthcare facilities; and Universal Waste Shipback Systems, a solution for the collection, transportation, and recycling of light bulbs, batteries, and other mercury containing devices.

More notable recent Sharps Compliance Corp. (NASDAQ:SMED) news were published by: which released: “Synchrony (SYF) Q4 Earnings and Revenues Beat Estimates –” on January 23, 2019, also with their article: “Sharp Compliance – Cleaning Up The Drugs In The U.S. – Seeking Alpha” published on November 14, 2016, published: “Stericycle A Man Among Boys In Medical Waste Market – Seeking Alpha” on November 07, 2012. More interesting news about Sharps Compliance Corp. (NASDAQ:SMED) were released by: and their article: “Tetra Tech Clinches Single-Award Contract From U.S. EPA – Nasdaq” published on February 27, 2019 as well as‘s news article titled: “CECE or SMED: Which Is the Better Value Stock Right Now? –” with publication date: January 31, 2019.

Sharps Compliance Corp. (NASDAQ:SMED) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.